Bristol-Myers Squibb Company (BMY) Q1 2008 Earnings Results

Bristol Myers Squibb Reports Q1 2008 Earnings, Stock Up 3.64%

Bristol Myers Squibb's earnings report showed a solid EPS of $0.42, although no revenue figures were disclosed. The stock reacted positively, rising 3.64%, likely driven by management's comments on innovation and strong product performance. Investors may view this as a sign of resilience in a challenging market environment.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.42	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a cautious optimism about the company's future. They emphasized their focus on maintaining strong operational performance.

Management highlighted ongoing commitment to innovation in drug development.

They noted strong performance in existing product lines despite market challenges.

Bristol Myers Squibb Reports Q1 2008 Earnings, Stock Up 3.64%

Key numbers

Management commentary

Bristol-Myers Squibb Company

More earnings this week

Bristol Myers Squibb Reports Q1 2008 Earnings, Stock Up 3.64%

Key numbers

Management commentary